ANTHIM®

(Obiltoxaximab)

Documentation

Patented
Approved 2016
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Antagonist
Target: Anthrax
Indication Category: Infection

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA